Success Metrics

Clinical Success Rate
82.9%

Based on 68 completed trials

Completion Rate
83%(68/82)
Active Trials
7(7%)
Results Posted
18%(12 trials)
Terminated
14(13%)

Phase Distribution

Ph early_phase_1
2
2%
Ph not_applicable
20
19%
Ph phase_3
14
13%
Ph phase_4
43
41%
Ph phase_2
14
13%
Ph phase_1
9
8%

Phase Distribution

11

Early Stage

14

Mid Stage

57

Late Stage

Phase Distribution102 total trials
Early Phase 1First-in-human
2(2.0%)
Phase 1Safety & dosage
9(8.8%)
Phase 2Efficacy & side effects
14(13.7%)
Phase 3Large-scale testing
14(13.7%)
Phase 4Post-market surveillance
43(42.2%)
N/ANon-phased studies
20(19.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

79.1%

68 of 86 finished

Non-Completion Rate

20.9%

18 ended early

Currently Active

7

trials recruiting

Total Trials

106

all time

Status Distribution
Active(8)
Completed(68)
Terminated(18)
Other(12)

Detailed Status

Completed68
Terminated14
unknown12
Active, not recruiting4
Withdrawn4
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
106
Active
7
Success Rate
82.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (2.0%)
Phase 19 (8.8%)
Phase 214 (13.7%)
Phase 314 (13.7%)
Phase 443 (42.2%)
N/A20 (19.6%)

Trials by Status

unknown1211%
active_not_recruiting44%
withdrawn44%
not_yet_recruiting11%
recruiting33%
completed6864%
terminated1413%

Recent Activity

Clinical Trials (106)

Showing 20 of 106 trialsScroll for more
NCT07500454Not Applicable

Analgesic Equivalence of NSAIDs and Tramadol in Acute Postoperative Pain Following Minimally Invasive Surgery

Completed
NCT06029296Early Phase 1

Diclofenac as a KMO Inhibitor

Active Not Recruiting
NCT07071012Not Applicable

Pain Control After Open Radical Nephrectomy: Thoracic Paravertebral Block Versus External Oblique Intercostal Block

Completed
NCT06566794Not Applicable

KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism

Completed
NCT06373978Phase 4

NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow

Recruiting
NCT07203651Not Applicable

Comparison Between Diclofenac and Sterile Water Injection for Relief of Labour Associated Bachache

Active Not Recruiting
NCT03595150Phase 2

Diclofenac for Prevention of Post-ERC Pancreatitis

Not Yet Recruiting
NCT06918340Phase 4

Evaluation of Analgesic Efficacy of Lidocaine and Diclofenac Spray in Radial Artery Blood Gas Sampling by Visual Analogue Scale and Perfusion Index

Active Not Recruiting
NCT06053411Early Phase 1

Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac

Recruiting
NCT06623929

Topical Treatments for Ankle Sprains

Active Not Recruiting
NCT03781544Phase 4

Effects of Opioids and NSAIDs on Sympathetic Nervous System and Vascular Function

Recruiting
NCT06251349

Comparative Analysis of Radiotherapeutic and Medical Procedures for the Prophylaxis of Heterotopic Ossifications

Completed
NCT06220279Not Applicable

Efficacy of Single Dose Rectal Diclofenac With Oral Diclofenac for the Relief of Perineal Pain Within 24 Hours After Episiotomy

Completed
NCT02183129Phase 4

Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee

Completed
NCT03949673Phase 2

Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip

Terminated
NCT02689024Phase 4

Delirium in Elderly Patients With Trauma of the Hip

Terminated
NCT03493490Phase 4

Neodolpasse® Infusion Solution Versus Diclofenac 75 mg Infusion in the Treatment of Postoperative Pain After Elective Knee Surgery

Completed
NCT03304379Phase 3

Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip

Completed
NCT03199924Phase 2

Treatment of Renal Colic in the Emergency Departement (ED).

Completed
NCT04511832Not Applicable

Comparative Effectiveness of Acupuncture and Nonsteroidal Anti-inflammatory Drugs for the Management of Aromatase Inhibitor Induced Arthralgia Among Breast Cancer Survivors

Completed

Drug Details

Intervention Type
DRUG
Total Trials
106